PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE
J.H. Best, E. Pelletier, D.B. SmithVolume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.02.533
File:
PDF, 57 KB
english, 2011